643 related articles for article (PubMed ID: 10666532)
1. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.
Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS
Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532
[TBL] [Abstract][Full Text] [Related]
2. Effects of intrathecal administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain.
Wang YX; Pettus M; Gao D; Phillips C; Scott Bowersox S
Pain; 2000 Feb; 84(2-3):151-8. PubMed ID: 10666519
[TBL] [Abstract][Full Text] [Related]
3. Spinal antinociception of synthetic omega-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium channel blocker, and its effects on morphine analgesia in chemical stimulus tests in rodent.
Yan LD; Liu YL; Zhang L; Dong HJ; Zhou PL; Su RB; Gong ZH; Huang PT
Eur J Pharmacol; 2010 Jun; 636(1-3):73-81. PubMed ID: 20361956
[TBL] [Abstract][Full Text] [Related]
4. Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain.
Atanassoff PG; Hartmannsgruber MW; Thrasher J; Wermeling D; Longton W; Gaeta R; Singh T; Mayo M; McGuire D; Luther RR
Reg Anesth Pain Med; 2000; 25(3):274-8. PubMed ID: 10834782
[TBL] [Abstract][Full Text] [Related]
5. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain.
Bowersox SS; Gadbois T; Singh T; Pettus M; Wang YX; Luther RR
J Pharmacol Exp Ther; 1996 Dec; 279(3):1243-9. PubMed ID: 8968347
[TBL] [Abstract][Full Text] [Related]
6. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.
Klotz U
Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978
[TBL] [Abstract][Full Text] [Related]
7. Suppression of formalin-induced nociception by cilnidipine, a voltage-dependent calcium channel blocker.
Koganei H; Shoji M; Iwata S
Biol Pharm Bull; 2009 Oct; 32(10):1695-700. PubMed ID: 19801830
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure changes after intrathecal co-administration of calcium channel blockers with morphine or clonidine at the spinal level.
Horvath G; Brodacz B; Holzer-Petsche U
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):270-5. PubMed ID: 12172710
[TBL] [Abstract][Full Text] [Related]
9. Regulation of spinal substance p release by intrathecal calcium channel blockade.
Takasusuki T; Yaksh TL
Anesthesiology; 2011 Jul; 115(1):153-64. PubMed ID: 21577088
[TBL] [Abstract][Full Text] [Related]
10. Spinally delivered N-, P/Q- and L-type Ca2+-channel blockers potentiate morphine analgesia in mice.
Fukuizumi T; Ohkubo T; Kitamura K
Life Sci; 2003 Oct; 73(22):2873-81. PubMed ID: 14511772
[TBL] [Abstract][Full Text] [Related]
11. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
12. The combined effects of N-type calcium channel blockers and morphine on A delta versus C fiber mediated nociception.
Pirec V; Laurito CE; Lu Y; Yeomans DC
Anesth Analg; 2001 Jan; 92(1):239-43. PubMed ID: 11133635
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
14. Spinal antinociceptive action of an N-Type voltage-dependent calcium channel blocker and the synergistic interaction with morphine.
Omote K; Kawamata M; Satoh O; Iwasaki H; Namiki A
Anesthesiology; 1996 Mar; 84(3):636-43. PubMed ID: 8659792
[TBL] [Abstract][Full Text] [Related]
15. Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
Wermeling DP
Pharmacotherapy; 2005 Aug; 25(8):1084-94. PubMed ID: 16207099
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
17. Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats.
Malmberg AB; Yaksh TL
Pain; 1995 Jan; 60(1):83-90. PubMed ID: 7715945
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of intrathecal ziconotide for the treatment of chronic pain.
Jain KK
Expert Opin Investig Drugs; 2000 Oct; 9(10):2403-10. PubMed ID: 11060815
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of antinociceptive effects of morphine by calcium-channel blockers at the level of the spinal cord.
Omote K; Sonoda H; Kawamata M; Iwasaki H; Namiki A
Anesthesiology; 1993 Oct; 79(4):746-52. PubMed ID: 8214754
[TBL] [Abstract][Full Text] [Related]
20. The neuroprotective effects of intrathecal administration of the selective N-type calcium channel blocker ziconotide in a rat model of spinal ischemia.
Burns LH; Jin Z; Bowersox SS
J Vasc Surg; 1999 Aug; 30(2):334-43. PubMed ID: 10436454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
